Skip to content

Effect of synchronous tDCS-rTMS combined with situational interactive rehabilitation training on motor function in patients with Parkinson's disease

Effect of synchronous tDCS-rTMS combined with situational interactive rehabilitation training on motor function in patients with Parkinson's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112500
Enrollment
Unknown
Registered
2025-11-14
Start date
2025-11-14
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Experimental group:rTMS+tDCS+situational interactive rehabilitation training
Control group:Sham rTMS + sham tDCS + situational interactive rehabilitation training

Sponsors

The First Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosis meets the standards of the "Chinese Parkinson's Disease Diagnostic Criteria (2016 edition)"; 2. H-Y stage = 3; 3. Vital signs are stable; 4. Able to walk independently and safely without assistance or the use of a cane, and can independently perform standing up, sitting, and standing movements; 5. Agree to undergo systematic motor function assessment, able to understand instructions from the therapist or device, and can complete the required movements; 6. Agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Those with secondary Parkinson's syndrome or overlapping Parkinson's syndrome; 2. Those with other severe physical or mental illnesses; 3. Individuals with metal implants in the skull; 4. Those using implanted electronic devices; 5. Individuals with concurrent tumor diseases; 6. Those with a history of epileptic seizures; 7. Individuals with other intracranial organic diseases; 8. Those with a history of cranial surgery or significantly increased intracranial pressure; 9. Individuals prone to bleeding; 10. Patients with local skin damage, inflammation, or hyperesthesia at the stimulation site.

Design outcomes

Primary

MeasureTime frame
Berg Balance Scale Score;Unified Parkinson’s Disease Rating Scale Part III,MDS-UPDRS ?;Balance evaluation;Gait kinematics analysis;Resting state EEG;Transcranial magnetic synchronized EEG;

Secondary

MeasureTime frame
Motor Evoked Potentials, MEP;

Countries

China

Contacts

Public ContactWang Yahui

The First Hospital of Hebei Medical University

yhwang197875@sina.com+86 186 3388 9576

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026